Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Travel support, Switzerland, Feb 6, 2020
| Reference number | 2020-00231 |
| Coordinator | Triquetra Medicines AB |
| Funding from Vinnova | SEK 5 187 |
| Project duration | January 2020 - February 2020 |
| Status | Completed |
The project aimed to establish contact with potential investors to strengthen the company´s network.
Positive results according to plan. Participation in the Swiss Nordic Bio 2020 conference led to new contacts.
n/a
The project description has been provided by the project members themselves and the text has not been looked at by our editors.
Last updated 6 March 2020
Reference number 2020-00231
